Abbott ~ Effective 3/11/2011 until further amended.

Abiomed, Inc. ~ Effective 1/30/2008 until further amended.

Alpha Oncology Inc. - Effective 11/18/11

Amgen, Inc. ~ Effective 8/18/2005 until further amended.

Astellas Pharma Global Development, Inc. ~ Effective 10/2/2014 - 10/1/2019

AstraZeneca Pharmaceuticals - Effective 2/19/2019

Bayer Healthcare Pharmaceuticals ~ Effective 10/14/2014 - 10/13/2019

Beckman Coulter ~ Effective 2/16/2011 - 2/15/2016

Biogen, Inc. ~ Effective 2/13/2014 - 2/12/2019

Boehringer Ingelheim Pharmaceuticals, Inc. ~ Effective 1/3/2017 - 1/2/2022

Boston Scientific Corporation - Effective 2/18/2021

Cardiac Pacemakers, Inc.

Celgene ~ Effective 5/2/2011 - 7/27/2022

Edwards Lifesciences

Eli Lilly: Lilly Research Laboratories ~ Effective 3/11/2005 until further amended.

Genentech, Inc. ~ Effective 5/31/17 - 5/30/27

Genzyme Corp.

Gilead ~ Effective 8/12/2013 - 5/21/2021

GlaxoSmithKline

Ilex Pharmaceuticals Corp.

Johnson and Johnson Vision Care, Inc. ~ Effective 10/10/2011 - 10/11/2019

Karyopharm Therapeutics - Effective 11/10/17

Merck & Co., Inc. ~ Effective 5/15/2014 until further amended. 

Novartis Pharmaceuticals Corporation ~ Effective 9/7/2005 - 8/31/2025

Novartis CTA/IIRP ~ Effective 9/25/2013 - 9/24/2018

Novo Nordisk, Inc. ~ Effective 12/20/2013 - 12/19/2018

Ortho Clinical - Effective 2/2/18

OSI Pharmaceuticals, Inc.- Expired 2015

Penumbra, Inc. - Effective 2/4/2021

Pharmaceutical Research Associates, Inc. - Effective 12/17/2020

Pharmacyclics - Effective 12/19/17

Purdue Pharma LP ~ Effective11/14/2013 - 11/13/2018

Sanofi-Aventis ~ Effective 1/3/2013 - 1/2/2018

Serono, Inc. ~ Effective 7/1/2006 until further amended.

Sunesis Pharmaceuticals ~ Effective 5/20/2011 until further amended.

UCB Biosciences, Inc. ~ Effective 8/19/2013 until further amended.

Vertex Pharmaceuticals Inc. ~ Effective 10/28/2021 through 10/27/2026

Warner Chilcott ~ Effective 8/2/2011 until further amended.

Active Master Clinical Trial Agreements as of November 29, 2017

RF also has master CDAs with 

AbbVie Inc - Effective 8/31/2021

AstraZeneca Pharmaceuticals LP/AstraZeneca LP ~ Effective 1/22/2015 - 1/21/2020

Boehringer Ingelheim Pharmaceuticals, Inc. ~ Effective 12/19/2016 - 12/18/2026

Janssen Research & Development - Effective 9/21/2021

SBU is currently negotiating MCTAs with AstraZeneca and CSL Behring